AsianScientist (Nov. 17, 2017) – QuintilesIMS has changed its name to IQVIA effective from November 6, 2017. The name change comes a year after a US$17.6 billion merger between Quintiles and IMS Health that formed the world’s largest contract research organization.
Beginning on November 15, 2017, equity shares of the company will trade on the NYSE under the new name and new ticker symbol “IQV.” Until then, IQVIA will continue to be listed under QuintilesIMS and symbol “Q” per the listing notification requirements of the NYSE.
“Our clients have been instrumental in our becoming IQVIA,” said IQVIA Chairman and CEO Ari Bousbib. “IMS Health and Quintiles came together because our clients were asking for better, faster ways to bring innovations to patients and capture the improvements the industry has been pursuing for years.
IQVIA’s client solutions are powered by the IQVIA CORE™, a proprietary system that leverages on the company’s curated healthcare information source, said to the largest in the world.
“Since the merger, we’ve worked to integrate our capabilities in advanced analytics, leading technologies and therapeutic expertise into powerful, differentiated offerings. Our vision is to outpace the inevitable progress of change across the life sciences and accelerate our ability to empower healthcare decision makers to meet the future head on,” Bousbib said.
———
Source: IQVIA; Photo: Shutterstock.
Disclaimer: This article does not necessarily reflect the views of AsianScientist or its staff.
